WuXi Biologics (Cayman) Inc. (WXIBF)
OTCMKTS · Delayed Price · Currency is USD
3.850
0.00 (0.00%)
At close: Aug 8, 2025
Accolade Market Cap
WuXi Biologics has a market cap or net worth of $15.97 billion as of August 13, 2025. Its market cap has increased by 177.70% in one year.
Market Cap
15.97B
Enterprise Value
15.68B
Revenue
2.56B
Ranking
n/a
PE Ratio
34.74
Stock Price
$3.85
Market Cap Chart
Since June 13, 2017, WuXi Biologics's market cap has increased from 4.11B to 15.97B, an increase of 288.73%. That is a compound annual growth rate of 18.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 15.33B | 65.13% |
| Dec 31, 2024 | 9.28B | -41.99% |
| Dec 29, 2023 | 16.00B | -50.63% |
| Dec 30, 2022 | 32.41B | -35.36% |
| Dec 31, 2021 | 50.14B | -7.43% |
| Dec 31, 2020 | 54.16B | 230.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.72M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.23M |
| Glass House Brands | 561.16M |
| American Oncology Network | 385.65M |
| Northwest Biotherapeutics | 332.06M |
| CytoDyn | 300.75M |